4.3 Mitophagy and metabolic-associated fatty liver diseases Metabolic associated fatty liver disease (MAFLD) refers to a series of diseases caused by multi-systemic metabolic dysfunction resulting in chronic liver damage, including hepatic steatosis, NAFLD, hepatic fibrosis, liver cirrhosis, hepatocellular carcinoma, and others ( In vitro , CP upregulates the protein levels of PGC-1, PPAR, PINK1, Parkin, ATG7, and LC3I/II in free FA (FFA)-induced NAFLD cell models, activates the PINK1-Parkin signaling pathway to promote mitophagy in liver cells, and inhibits FFA-induced OS and lipid accumulation
Nov 2019;5(6):1146-1151
Understanding the ideal use cases helps you determine whether Integrative Peptides aligns with your goals
4.3 The efficacy and mechanism of natural medicine At present, research on natural medicines for combating blue light damage is mostly focused on antioxidants and anti-inflammatory drugs
Peptides and Performance-Enhancing Drug Tests Peptides like BPC-157, IGF-1 LR3, Ipamorelin, and HCG are often studied for their ability to enhance physical performancewhether in terms of muscle recovery, strength, or endurance
Pathophysiology, diagnosis, and management of endometriosis